Neonatal group B streptococcus sepsis after negative screen in a patient taking oral antibiotics

David D. Kim, Sarah M. Page, David S. McKenna, Catherine M. Kim

Producción científica: Articlerevisión exhaustiva

1 Cita (Scopus)


BACKGROUND: Group B streptococcus (GBS) is a leading cause of serious neonatal infection. Neonatal morbidity and mortality can be reduced by appropriate prenatal screening and intrapartum chemoprophylaxis. CASE: A 20-year-old primigravida was treated with oral antibiotics at 35 weeks for a recurrent urinary tract infection. Her GBS screen following the antibiotic treatment showed a negative culture. The patient, therefore, did not receive intravenous antibiotics during her induction of labor for mild preeclampsia. The infant developed early onset neonatal GBS pneumonia and sepsis. CONCLUSION: Oral antibiotics can cause a temporary negative culture in a GBS-colonized patient. Relying on a negative culture for management may not be appropriate in a patient treated with oral antibiotics. Additional studies are necessary to elucidate the effects of oral antibiotics on GBS.

Idioma originalEnglish (US)
Páginas (desde-hasta)1259-1261
Número de páginas3
PublicaciónObstetrics and gynecology
N.º5 II
EstadoPublished - may 2005
Publicado de forma externa

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Profundice en los temas de investigación de 'Neonatal group B streptococcus sepsis after negative screen in a patient taking oral antibiotics'. En conjunto forman una huella única.

Citar esto